Mortgage rates slingshot higher as tariff uncertainty roils markets

Mortgage rates slingshot higher as tariff uncertainty roils markets


A completed planned development is seen in Ashburn, Virginia, on Aug. 14, 2024.

Andrew Caballero-Reynolds | AFP | Getty Images

Mortgage rates hit their highest level in over a month this week, reversing course after a period of improvement.

The average rate on the 30-year fixed rate jumped 22 basis points Monday and another 3 basis points Tuesday to 6.85%, according to Mortgage News Daily, fully erasing the decline from last week.

Much like the stock market, the bond market has been on a roller coaster over the last week, and mortgage rates are along for the ride.

Last week the 30-year fixed rate dropped to the lowest level since last October after President Donald Trump announced global tariffs. The announcement sent the stock market plunging and investors rushing to the relative safety of the bond market. As a result, bond yields fell. Mortgage rates follow loosely the yield on the 10-year Treasury.

“Last week’s drop was a knee-jerk reaction that priced in more dire economic expectations,” said Matthew Graham, chief operating officer at Mortgage News Daily.

“So far this week, bonds are less panicked after several officials have discussed tariff negotiations and deals. Just this morning, when [Treasury Secretary Scott] Bessent referred to tariffs as a melting ice cube, we saw an immediate reaction in the market. Bottom line, rates took a lead off last week as economic fears surged. Now they’re back on base and waiting for the next pitch,” he said.

The initial drop in mortgage rates last week had housing watchers cheering a potential boost to the lackluster spring market. Mortgage rates had been moving in a very narrow range since the end of February, lower than last year, but not by much. Homebuyers are also contending with high, and still rising, home prices, as well as dwindling confidence in the broader economy and their own employment.

“The spring housing season is beginning with more sellers and a growing number of homes for sale,” said Danielle Hale, chief economist at Realtor.com, in its March housing report. “But the high cost of buying coupled with growing economic concerns suggest a sluggish response from buyers in early spring.”

The biggest drop in rates so far this year came not last week, but in January and February, when the 30-year fixed mortgage fell from a high of 7.26% to 6.74%. Despite that decline, pending home sales, which are a measure of initial signed contracts on existing homes, and therefore the most recent indicator of activity, rose just 2% in February from January, according to the National Association of Realtors. Sales were still 3.6% lower than February 2024.

“Despite the modest monthly increase, contract signings remain well below normal historical levels,” said Lawrence Yun, NAR’s chief economist. “A meaningful decline in mortgage rates would help both demand and supply – demand by boosting affordability, and supply by lessening the power of the mortgage rate lock-in effect.”

The next significant move in mortgage rates could come as the market digests new economic data, namely Thursday’s consumer price index and Friday’s produce price index reports. Both have a strong track record of influencing rate momentum.

Don’t miss these insights from CNBC PRO



Source

Nike cuts 1,400 roles in second round of layoffs this year
Business

Nike cuts 1,400 roles in second round of layoffs this year

People walk past a Nike store in New York City, on April 2, 2025. Kylie Cooper | Reuters Nike announced a new round of layoffs on Thursday impacting approximately 1,400 roles across the organization, mostly concentrated in its technology department. In a note from COO Venkatesh Alagirisamy, the company said the layoffs were part of […]

Read More
Trump administration moves to reclassify cannabis in major shift that could expand research
Business

Trump administration moves to reclassify cannabis in major shift that could expand research

The Trump administration moved Thursday to reclassify cannabis under federal law, which could significantly expand scientific research into the drug’s medical uses. The change would not legalize the drug at the federal level, but shift cannabis from its current status as a Schedule I substance to Schedule III under the U.S. Drug Enforcement Administration’s controlled […]

Read More
Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free
Business

Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free

U.S. President Donald Trump (C) speaks during an event on advancing health care affordability in the Oval Office of the White House on April 23, 2026 in Washington, DC. Alex Wong | Getty Images Regeneron agreed to lower U.S. drug prices for some Americans as part of a deal with President Donald Trump, the White […]

Read More